Raymond Scott Turner MD PhD (He/Him)

Neuroimaging, Neurodegenerative, Dementia & Geriatrics

Vice Chair for Clinical Research, Professor of Neurology, and Director of the Memory Disorders Program at Georgetown University

Join to view full profile

4000 Reservoir Road, NWSuite 177, Building DWashington, DC 20057
Phone+1 202-687-7337
Fax+1 202-784-4332

Dr. Turner is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Turner's full profile Already have an account?

Summary

Raymond Scott Turner, PhD, MD, based in Washington, DC, is a neurologist specializing in neuroimaging and neurodegenerative conditions, with a focus on dementia and geriatrics. Dr. Turner completed medical school at Emory University and neurology residency and postdoctoral fellowship at the University of Pennsylvania. Currently, Dr. Turner holds positions as Vice Chair of Neurology at MedStar Georgetown University Hospital and Professor at Georgetown University School of Medicine, where Dr. Turner also directs the Memory Disorders Program. Dr. Turner's research expertise includes dementia, Alzheimer's disease, and related neurodegenerative diseases, with numerous publications in these areas. Dr. Turner is actively involved in several clinical trials aimed at Alzheimer's treatment. Honors include being a Fellow of both the American Academy of Neurology and the American Neurological Association.

Education & Training

Penn MedicinePost-Doctoral Fellowship, 1992 - 1995
University of Pennsylvania Health SystemResidency, Neurology, 1989 - 1992
University of Pennsylvania Health SystemInternship, Internal Medicine, 1988 - 1989
Emory University School of MedicineClass of 1988, M.D.
Emory UniversityPh.D., Pharmacology, 1979 - 1984

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

DC State Medical License 2008 - 2027
VA State Medical License 2019 - 2026
MI State Medical License 1995 - 2011
PA State Medical License 1990 - 1996
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Fellow American Academy of Neurology, 2019
Fellow (elected) American Neurological Association, 2006
Paul Beeson Career Development Award in Aging Research American Federation for Aging Research, 1998-2001

Clinical Trials

AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid Start of enrollment: 2020 Jul 14
ACTIVE_NOT_RECRUITING
PHASE3
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease Start of enrollment: 2023 Jun 28
ACTIVE_NOT_RECRUITING
PHASE2
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease Start of enrollment: 2025 Jul 14
RECRUITING
PHASE3

Publications & Presentations

PubMed

Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.
Dustin B Hammers, Angelina Polsinelli, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah
Alzheimer's & Dementia. 2026-05-03
Cognitive dispersion profiles and prediction of cognitive change in early-onset dementias: Results from LEADS.
Dustin B Hammers, Elodie Foster, Ani Eloyan, Maryanne Thangarajah, Alexander Taurone
Alzheimer's & Dementia. 2026-05-01
2 citations
Speech production as an artificial intelligence-based 'process' measure of cognition sensitive to mild cognitive impairment and Alzheimer's disease.
Ross Divers, Alex S Cohen, Brita Elvevåg, Chelsea Chandler, Raymond Scott Turner
The Clinical Neuropsychologist. 2026-04-01

Books/Book Chapters

Neuropsychology of Cortical Dementias
Chapter: Primary Progressive Aphasia
Page 265 - 284Friedman R, Long S, Turner RSEditors: Noggle CA, Dean RS.Springer, Inc., New York2015
Alzheimer's Disease. Targets for New Clinical Diagnostic and Therapeutic Strategies
Chapter: Alzheimer's Disease: Clinical Aspects
Page 211 - 230Turner RSEditors: Wegrzyn D, Rudolph AS.CRC Press, Boca Raton2012
Alzheimer's Disease: New Advances
Chapter: Modulation of neuronal APP metabolism by X11alpha/mint-1/APBA1
Page 385 - 392Saluja I, Saunders TL, Turner RSEditors: Iqbal K, Winblad B, Avila J.Medimond, Bologna2007

Grant Support

A multidisciplinary study of Alzheimer's disease risk factors in Blacks/African Americans living with HIVNIH/NIA2025–2030
Alzheimer's Clinical Trials ConsortiumNIH/NIA2023–2028
Using digital signals from credit data for early detection of Alzheimer's disease and related dementiasNIH/NIA2023–2027

Committees

Site PI, Steering Committee member, Alzheimer's Clinical Trials Consortium, University of Southern California, San Diego 2015 - Present

Professional Memberships

American Academy of Neurology - AAN
Fellow
American Neurological Association
Fellow
International Society to Advance Alzheimer's Research and Treatment (ISTAART)
Member